ask="4.75"
ask_size="400"
average_daily_volume="251710"
bid="4.51"
bid_size="200"
book_value="0.56"
change="+0.57"
change_from_200_day_moving_average="1.99"
change_from_50_day_moving_average="1.51"
change_from_52_week_high="-0.13"
change_From_52_week_low="2.45"
change_in_percent="+14.47%"
close="4.51"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.31"
ebitda="-5.76M"
eps_estimate_current_year="-0.30"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.91"
ex_dividend_date="N/A"
float_shares="16233000"
high="4.64"
high_52_weeks="4.64"
last_trade_date="2/22/2017"
last_trade_price="4.51"
last_trade_size="1000"
last_trade_time="4:00pm"
low="3.81"
low_52_weeks="2.06"
market_capitalization="84.28M"
moving_average_200_day="2.52"
moving_average_50_day="3.00"
name="Brainstorm Cell Therapeutics In"
notes="N/A"
one_year_target_price="6.00"
open="4.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+78.88%"
percent_change_from_50_day_moving_average="+50.22%"
percent_change_from_52_week_high="-2.80%"
percent_change_from_52_week_low="+118.92%"
previous_close="3.94"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.00"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18687000"
short_ratio="7.59"
stock_exchange="NCM"
symbol="BCLI"
volume="1188270"
weeks_range_52="2.06 - 4.64"
